Provided by Tiger Trade Technology Pte. Ltd.

Sanofi SA

42.48
-0.6600-1.53%
Post-market: 42.590.1100+0.26%16:23 EDT
Volume:2.24M
Turnover:95.37M
Market Cap:101.78B
PE:22.78
High:42.77
Open:42.75
Low:42.34
Close:43.14
52wk High:52.68
52wk Low:40.89
Shares:2.40B
Float Shares:2.16B
Volume Ratio:0.88
T/O Rate:0.10%
Dividend:2.37
Dividend Rate:5.57%
EPS(TTM):1.86
EPS(LYR):3.76
ROE:5.71%
ROA:5.09%
PB:1.28
PE(LYR):11.30

Loading ...

Sanofi Stops Late-Stage Trial of Autoimmune Disease Therapy After Interim Review

MT Newswires Live
·
Jun 10

Sanofi to Stop Late-Stage Study of Immune-Disorder Drug

Dow Jones
·
Jun 10

European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading

MT Newswires Live
·
Jun 08

Sanofi's Subcutaneous Sarclisa Approved in EU Across Multiple Myeloma Indications

MT Newswires Live
·
Jun 08

Movement Alert|Sanofi Rises 4.59% in Regular Trading, First-in-Class Drug Venglustat Granted FDA Priority Review for Rare Disease

Market Focus
·
Jun 04

Movement Alert|Sanofi Rises 3.09% in Pre-Market Trading, First-in-Class Drug Venglustat Granted FDA Priority Review

Market Focus
·
Jun 04

Sanofi's Groundbreaking Drug Venglustat Seeks FDA Approval for Type 3 Gaucher Disease

Stock News
·
May 28

Sanofi announces FDA grants priority review to venglustat new drug application

TIPRANKS
·
May 28

Sanofi Granted FDA Priority Review for Potential Treatment of Rare Gaucher Disease

MT Newswires Live
·
May 28

Sanofi reports ElevAATe trial of efdoralprin alfa meets primary endpoint

TIPRANKS
·
May 19

Regeneron Pharmaceuticals Trial Miss May Raise Broader Strategy Questions, RBC Says

MT Newswires Live
·
May 18

Sanofi’s SAR445399 Lung Trial Moves Ahead: What Investors Should Watch

TIPRANKS
·
May 15

Google AI legend raises big money for startup targeting this cutting-edge goal

Dow Jones
·
May 13

Global Pharmaceutical Giants Report Robust Earnings, Increasing Investments in China

Deep News
·
May 07

Sanofi Needs Acquisitions to Overcome Pipeline Disappointments -- Market Talk

Dow Jones
·
May 07

Regeneron, Sanofi present results from Dupixent Phase 4 trial

TIPRANKS
·
May 05

Sanofi appoints Belén Garijo CEO, effective May 1, 2026

Reuters
·
May 05

Sanofi invests C$294M to expand AI Center of Excellence in Toronto

TIPRANKS
·
May 05

European Equities Traded in the US as American Depositary Receipts Start Week Lower

MT Newswires Live
·
May 04

Regeneron Flags FDA Delays For Eylea HD Prefilled Syringe

Benzinga Earnings
·
Apr 30